Home
About
Overview
Sharing Data
ORCID
Help
History (7)
MEKK2 mediates aberrant ERK activation in neurofibromatosis type I.
Nanomedicine
Selenious Acid
Cochlear implantation in a patient with neurofibromatosis type 1 and profound hearing loss: evidence to support a cochlear site of lesion.
New developments in neurofibromatosis type 2 and vestibular schwannoma.
See All 7 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
New developments in neurofibromatosis type 2 and vestibular schwannoma.
Ren Y, Chari DA, Vasilijic S, Welling DB, Stankovic KM. New developments in neurofibromatosis type 2 and vestibular schwannoma. Neurooncol Adv. 2021 Jan-Dec; 3(1):vdaa153.
View in:
PubMed
authors with profiles
Divya A Chari MD